Total Payments
$3,490
2024 Payments
$815.35
Companies
24
Transactions
130
Medicare Patients
49,106
Medicare Billing
$4.7M
Payment Breakdown by Category
Food & Beverage$3,395 (97.3%)
Education$95.44 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,395 | 127 | 97.3% |
| Education | $95.44 | 3 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | $520.29 | 8 | $0 (2024) |
| ABBVIE INC. | $501.66 | 20 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $486.56 | 10 | $0 (2024) |
| Allergan, Inc. | $357.64 | 20 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $299.58 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $296.95 | 19 | $0 (2023) |
| Alcon Vision LLC | $241.89 | 7 | $0 (2024) |
| Oyster Point Pharma, Inc. | $130.59 | 5 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $115.49 | 4 | $0 (2024) |
| Shire North American Group Inc | $97.75 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $815.35 | 27 | Bausch & Lomb Americas Inc. ($266.59) |
| 2023 | $732.47 | 23 | ABBVIE INC. ($315.75) |
| 2022 | $322.97 | 12 | Johnson & Johnson Surgical Vision, Inc. ($119.98) |
| 2021 | $531.91 | 20 | Alcon Vision LLC ($169.26) |
| 2020 | $298.16 | 15 | Allergan, Inc. ($160.54) |
| 2019 | $339.07 | 15 | Kala Pharmaceuticals, Inc. ($207.86) |
| 2018 | $195.25 | 8 | Johnson & Johnson Surgical Vision, Inc. ($77.63) |
| 2017 | $255.28 | 10 | Shire North American Group Inc ($97.75) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| 12/17/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: EYE CARE | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 11/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: EYE CARE | ||||||
| 11/18/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/10/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/08/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: SOLUTION/ DROPS | ||||||
| 09/10/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Ophthalmology | ||||||
| 08/26/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $91.86 | General |
| 08/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Ophthalmology | ||||||
| 07/26/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: EYE CARE | ||||||
| 07/21/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis IOL (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Optics | ||||||
| 07/02/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL | Food and Beverage | In-kind items and services | $125.50 | General |
| 06/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/19/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Dry eyes | ||||||
| 05/29/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Ophthalmology | ||||||
| 03/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/11/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Dry eyes | ||||||
| 02/23/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Ophthalmology | ||||||
| 02/07/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: EYE CARE | ||||||
| 02/06/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Dry eyes | ||||||
| 01/29/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 13,852 | 17,904 | $24.2M | $1.4M |
| 2022 | 28 | 12,627 | 16,655 | $21.8M | $1.3M |
| 2021 | 28 | 12,125 | 15,903 | $18.7M | $1.2M |
| 2020 | 34 | 10,502 | 13,558 | $14.6M | $864,732 |
Total Patients
49,106
Total Services
64,020
Medicare Billing
$4.7M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 1,818 | 3,832 | $2.9M | $282,975 | 9.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,511 | 1,918 | $1.4M | $193,637 | 13.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 2,117 | 2,271 | $1.7M | $122,713 | 7.2% |
| 68760 | Repair tear duct opening by heat, tying, or laser surgery | Office | 2023 | 265 | 372 | $1.9M | $110,077 | 5.9% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 142 | 218 | $4.4M | $100,714 | 2.3% |
| 65778 | Placement of amniotic membrane on eye surface for wound healing | Office | 2023 | 42 | 74 | $259,000 | $91,835 | 35.5% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 62 | 92 | $2.0M | $59,066 | 2.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 1,586 | 1,905 | $1.7M | $57,718 | 3.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 1,803 | 2,006 | $1.0M | $45,426 | 4.5% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 1,705 | 2,048 | $1.0M | $41,108 | 4.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 108 | 137 | $1.0M | $40,151 | 3.9% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Office | 2023 | 81 | 149 | $1.1M | $39,695 | 3.6% |
| 67700 | Incision and drainage of abscess of eyelid | Office | 2023 | 99 | 152 | $304,000 | $39,566 | 13.0% |
| 92250 | Photography of the retina | Office | 2023 | 1,107 | 1,256 | $879,200 | $39,006 | 4.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 267 | 267 | $220,275 | $31,142 | 14.1% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 129 | 136 | $408,000 | $26,102 | 6.4% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 22 | 28 | $280,000 | $20,370 | 7.3% |
| 92134 | Imaging of retina | Office | 2023 | 275 | 301 | $270,900 | $10,315 | 3.8% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 217 | 217 | $390,600 | $8,611 | 2.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 17 | 18 | $360,000 | $7,817 | 2.2% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 30 | 30 | $120,000 | $7,495 | 6.2% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 65 | 65 | $48,750 | $4,656 | 9.6% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 203 | 203 | $60,900 | $1,986 | 3.3% |
| 92132 | Imaging of front third of eye | Office | 2023 | 59 | 61 | $54,900 | $1,625 | 3.0% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 56 | 81 | $243,000 | $1,413 | 0.6% |
About Dr. Gregory Harmon, MD
Dr. Gregory Harmon, MD is a Ophthalmology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386731479.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Harmon, MD has received a total of $3,490 in payments from pharmaceutical and medical device companies, with $815.35 received in 2024. These payments were reported across 130 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,395).
As a Medicare-enrolled provider, Harmon has provided services to 49,106 Medicare beneficiaries, totaling 64,020 services with total Medicare billing of $4.7M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location New York, NY
- Active Since 10/09/2006
- Last Updated 03/20/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1386731479
Products in Payments
- DURYSTA (Drug) $490.87
- XIIDRA (Drug) $381.41
- INVELTYS (Drug) $299.58
- LUMIGAN (Drug) $231.86
- enVista MX60 IOL (Device) $178.01
- AcrySof IQ VIVITY IOL (Device) $136.36
- Tecnis Simplicity (Device) $133.33
- TYRVAYA (Drug) $130.59
- Tecnis IOL (Device) $122.30
- XDEMVY (Drug) $115.49
- TearScience Lipiflow System (Device) $77.63
- Catalys Laser System (Device) $67.05
- ILUX (Device) $63.50
- OMNI (Device) $62.96
- TEPEZZA (Biological) $54.97
- ILEVRO (Drug) $49.79
- OXERVATE (Drug) $45.08
- Clareon (Device) $42.03
- RESTASIS (Drug) $36.61
- iStent inject Trabecular Micro-Bypass Stent System (Device) $26.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New York
Dr. Tsontcho Ianchulev, M.d. Mph, M.D. MPH
Ophthalmology — Payments: $21.4M
Ophthalmology $21.4M
Dr. Nathan Radcliffe, M.d, M.D
Ophthalmology — Payments: $2.2M
Ophthalmology $2.2M
Dr. Joshua Young, M.d, M.D
Ophthalmology — Payments: $805,605
Ophthalmology $805,605
Dr. Raymond Fong, M.d, M.D
Ophthalmology — Payments: $581,936
Ophthalmology $581,936
Joseph Panarelli, M.d, M.D
Ophthalmology — Payments: $525,201
Ophthalmology $525,201
David Guyer
Ophthalmology — Payments: $491,407
Ophthalmology $491,407